This meta-analysis shows that serum vitamin D levels are inversely associated with NAFLD, supporting that patients with low vitamin D patients might benefit from proper supplementation. Read More

This review articles summarizes the current evidence on the efficacy of dietary interventions in the treatment of NAFLD. Read More

2020 started with an important discussion about the terminology to be used regarding Non Alcoholic Fatty Liver Disease (NAFLD). In this exclusive interview for the PanNASH web site, Prof Sven Francque discusses the rationale of this change and the possible impact in clinical practice

This editorial provides an insightful overview on the use of thyroid hormone receptor agonists as therapeutics for NASH.

This is a small pilot trial indicating that high-dose vitamin E supplementation for 24 weeks improves biomarkers of NASH in HIV-infected individuals.

The onsite International Liver Congress™ 2020, planned for 25–28 August, turns to an immersive and exciting digital event –The Digital International Liver Congress™ 2020, which will be held 27–29 August 2020.

In this Expert perspective video, Prof Sven Francque explains how to make the distinction between NAFL and NASH. This is important even though in clinical practice there is a continuum between the two. In the pathophysiology of NASH there is a complex interplay between different organs. Adipose tissue dysfunction is an important driver of disease.

This cohort study demonstrates that healthy eating habits are inversely correlated with NASH; moreover, high adherence to dietary recommendation was associated with lower risk for cancer-related and all-cause mortality.

This editorial discusses how results from clinical trials in adult NAFLD patients can be translated to improved therapies of NAFLD in children and adolescents.

PPARs are highly relevant to NAFLD28. When it is approached from the standpoint of a systemic disease involving metabolic changes in Adipose tissue, skeletal muscle, liver and endothelium.